Abstract:Radiotherapy is one common curative treatment choice for esophageal squamous cell carcinoma (ESCC). Increasing evidences have demonstrated that long noncoding RNAs (LncRNAs) were closely associated with tumor initiation and progression. Whether LncRNAs were involved in regulating tumor radioresponse and tumor microenvironment influenced LncRNAs expressions in cancer cells have as yet remained unknown. Our study aimed to investigate the effect of LncRNAs on the radioresistance and the mechanisms involved in ESCC. By qRT-PCR analysis, the mRNA levels of 94 cancer-related LncRNAs in LncRNAs & disease database were examined in tumor tissues of ESCC patients (n=23) and their matched adjacent normal tissues (n=23). The effect of LncRNAs on tumor radioresistance was investigated in vitro by clonogenic survival assay, detection of DNA double-strand breaks (DSBs) and by flow cytometry analysis on cell apoptosis. By lentivirus transduction, the expression of objective LncRNA was stably down-regulated. By establishment of xenograft tumor models in BALB/c nude mice, the effect of LncRNAs on radioresistance was investigated in vivo. By primary culture, CAFs (cancer-associated fibroblasts), a main component of tumor microenvironment, had been successfully isolated from tumor tissues of two ESCC patients, respectively. By co-culture of CAFs and ESCC cells, the effect of CAFs on LncRNAs expressions in cancer cells was investigated. DNM3OS among the 94 cancer-related LncRNAs was found to be highly expressed with an average 6.43 fold increase in tumor tissues of ESCC patients compared with in matched adjacent normal tissues. In ESCC cells KYSE-30, KYSE-140, KYSE-150, KYSE-180 and KYSE-450, the expressions of DNM3OS were also significantly higher than that in normal esophageal epithelial cell HFL-1, and further increased following 4 Gy of radiation. Down-regulation of DNM3OS expression significantly radiosensitized KYSE-30 and KYSE-140, inducing decreased clonogenic survival and increased DSBs and cell apoptosis by inhibiting DNA damage repair response. Stable down-regulation of DNM3OS expression in KYSE-30 and KYSE-140 also significantly improved the radiosensitivity of xenograft tumor models. Furthermore, we found CAFs were capable of promoting DNM3OS expression in ESCC cells with an approximately 15 fold increase in a TNFSF4 (Tumor Necrosis Factor Superfamily, Member 4)-dependent manner. Co-culture of ESCC cells and CAFs significantly enhanced the radioresistance as a result of increased DNM3OS expression. Our study highlighted CAFs-promoted DNM3OS in ESCC cells as an attractive target to improve the radiosensitivity.

CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma

CAFs-Secreted CXCL1 Mediated Radioresistance by Regulating DNA Damage Response in an ROS-Dependent Manner in Esophageal Squamous Cell Carcinoma

Targeting CAFs-Secreted TGFβ1 Signaling to Radiosensitize Esophageal Squamous Cell Carcinoma in Vitro and in Vivo

Cancer‐associated Fibroblasts Mediated Chemoresistance by a FOXO1/TGFβ1 Signaling Loop in Esophageal Squamous Cell Carcinoma

FAP positive cancer-associated fibroblasts promote tumor progression and radioresistance in esophageal squamous cell carcinoma by transferring exosomal lncRNA AFAP1-AS1

Cancer associated fibroblasts-derived exosomes contribute to radioresistance through promoting colorectal cancer stem cells phenotype

Collagen 1-mediated CXCL1 secretion in tumor cells activates fibroblasts to promote radioresistance of esophageal cancer

Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma

CAFs-Promoted LncRNA DNM3OS Conferred Radioresistance by Regulating DNA Damage Response in a TNFSF4-Dependent Manner in Esophageal Squamous Cell Carcinoma

ZFX promotes tumorigenesis and confers chemotherapy resistance in esophageal squamous cell carcinoma

Nrf2 promotes esophageal squamous cell carcinoma (ESCC) resistance to radiotherapy through the CaMKIIα-associated activation of autophagy

Population and single‑cell transcriptome analyses reveal diverse transcriptional changes associated with radioresistance in esophageal squamous cell carcinoma

Hypoxia-Induced Senescent Fibroblasts Secrete IGF1 to Promote Cancer Stemness in Esophageal Squamous Cell Carcinoma

Xrcc3 is A Promising Target to Improve the Radiotherapy Effect of Esophageal Squamous Cell Carcinoma

FOXK1 regulates malignant progression and radiosensitivity through direct transcriptional activation of CDC25A and CDK4 in esophageal squamous cell carcinoma

Cancer-associated Fibroblast–promoted LncRNA DNM3OS Confers Radioresistance by Regulating DNA Damage Response in Esophageal Squamous Cell Carcinoma

Chemoresistant Fibroblasts Dictate Neoadjuvant Chemotherapeutic Response of Head and Neck Cancer Via TGFα-EGFR Paracrine Signaling

The AEG-1-USP10-PARP1 Axis Confers Radioresistance in Esophageal Squamous Cell Carcinoma Via Facilitating Homologous Recombination-Dependent DNA Damage Repair.

CBX4 contributes to radioresistance by regulating autophagic activity in esophageal squamous cell carcinoma

Elevated HNF1A expression promotes radiation-resistance via driving PI3K/AKT signaling pathway in esophageal squamous cell carcinoma cells

Cancer-associated Fibroblasts Facilitate DNA Damage Repair by Promoting the Glycolysis in Non-Small Cell Lung Cancer.